Please login to the form below

ODD

This page shows the latest ODD news and features for those working in and with pharma, biotech and healthcare.

Pro bono publico

7. Agree on an exit plan at the start. It may sound odd talking about the end of the relationship before it has even begun, but that transparency is essential to

Latest news

FDA gives orphan drug status to Avidity’s rare muscular dystrophy treatment

The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Avidity Biosciences’ AOC 1020 for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD), a rare muscle-weakening ... The candidate will now
GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis

GSK’s Benlysta (belimumab) has been given Orphan Drug Designation (ODD) by the US Food and Drug Administration for the potential treatment of systemic sclerosis (SSc), the company announced. ... The antibody will now benefit from the incentives given
UK study reveals Omicron variant ‘substantially less likely’ to cause long Covid

The new study by King’s College London found that the odds of experiencing long COVID were between 20-50% less during the Omicron period versus the Delta period. ... A new study by researchers at King’s College London on the risk of long COVID after
FDA grants orphan drug status to Allogene’s BCMA-targeted treatment for multiple myeloma

The US Food and Drug Administration (FDA) has granted orphan-drug designation (ODD) to Allogene Therapeutics’ ALLO-715. ... We are pleased to have received ODD for ALLO-715 just months after the FDA granted RMAT designation.
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial

The COVID-19 patients who received the INF-beta-1a candidate had ‘greater odds of improvement’ on the World Health Organization’s (WHO) Ordinal Scale for Clinical Improvement (OSCI) on day

More from news
Approximately 1 fully matching, plus 105 partially matching documents found.

Latest Intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines

communities have higher odds of later-stage diagnoses of breast and lung cancers.
Healthcare creatives need to be more like Bryson

Odd bedfellows? Whether you’re a golf fan or not, the approach may seem unusual.
The value of Patient Support Programmes

We know from our research that patients have ways of seeing and understanding their condition and treatment that are often at odds with the medical model.
The importance of pharma intelligence in setting brand strategy

Companies that remember this and execute well in the four categories (primary CI, secondary CI, TPP and CS) assure the greatest odds of success.
Gut instincts lead Takeda to GI pipeline success

Focused R&D strategy. “The odds were against Takeda because it had no heritage in IBD and there were several anti-TNFs on the market, so it is a testiment to

More from intelligence
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest from PMHub

How nature can help you manage the pressures of agency life

The vibe may be completely at odds with your wellbeing policy.
4 ways to recruit Alzheimer’s disease patients for your clinical trial

Misplacing things or putting them in odd places. Confusion around the date or time of day.
TikTok and diabetes awareness

Home of viral dances, lip syncs and all manner of content that makes millennials suddenly feel desperately old, TikTok might seem an odd place to raise awareness of chronic health conditions
Can patient insights improve clinical trial recruitment strategies?

By delivering messages that resonate with the audience because of insights gathered, marketers can boost the odds of engaging and converting users by appealing directly to their likes, needs, interests and
How will the Tories’ historic win shape the NHS?

first glance, to be at odds with the Long-term Plan’s ambition to take more care out of hospitals.

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

Subscribe to our email news alerts

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer

PMHub

Add my company

Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story: ...
Working together to achieve better patient pathways: Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.: How design can lead improvement within Pharma...

Email:
Password:

Please login to the form below

ODD

Subscribe to our email news alerts

Quick links